Conference
A PHASE IB COMBINATION STUDY OF RO4929097 (RO), A GAMMA-SECRETASE INHIBITOR, AND TEMSIROLIMUS (TEM) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
Authors
Diaz-Padilla I; Hotte SJ; Ivy SP; Oza AM; Hirte HW; Razak ARA; Chen EX; Garcia IB; Siu L; Bedard P
Volume
23
Pagination
pp. 156-156
Publisher
OXFORD UNIV PRESS
Publication Date
September 1, 2012
Name of conference
37th Congress of the European-Society-for-Medical-Oncology (ESMO)
Conference place
Vienna, AUSTRIA
Conference start date
September 28, 2012
Conference end date
October 2, 2012
Conference proceedings
ANNALS OF ONCOLOGY
ISSN
0923-7534